Skip Main Navigation
Page Content
This event has ended

SoCalBio Networking Forum: Emerging Oncology Drugs

Southern California Biomedical Council

Thursday, August 28, 2014 from 4:00 PM to 7:00 PM (PDT)

SoCalBio Networking Forum: Emerging Oncology Drugs

Ticket Information

Ticket Type Sales End Price Fee Quantity
Non-Member Ended $75.00 $5.12
SoCalBio Member Ended $50.00 $3.74
Academic/Non-Profit Ended $50.00 $3.74
Student Ended $25.00 $2.37

Who's Going

Loading your connections...

Share SoCalBio Networking Forum: Emerging Oncology Drugs

Event Details

Featuring a panel discussion on

"New Oncology Drugs Under Development in Southern California"  

Join us for an evening of networking and information exchange about new oncology technologies and products under development in the Greater Los Angeles region


Thomas Lobl, PhD

Emerging Tech. Strategist

Alfred Mann Foundation

(Santa Clarita)

The Alfred Mann Foundation is a medical research foundation dedicated to bringing advanced medical technologies to the public to provide significant improvements to the health, security and quality of life for people suffering from debilitating medical conditions. 


Alan Auerbach

President & CEO

Puma Biotechnology

(Los Angeles)

Stephanie Hsieh

President & CEO

Meditope Bioscieces


Lena A. Basile, Ph.D.

President & CEO



 Manish Singh, PhD

Chairman & CEO

Lion Biotechnologies

(Woodland Hills)

Puma Biotechnology, Inc., is a development stage biopharmaceutical company developing PB-272 (oral neratinib), a potent irreversible tyrosine kinase inhibitor, for the treatment of patients with HER2 positive metastatic breast cancer.

Meditope Biosciences is developing best-in-class antibody-based cancer products. Discovered at City of Hope, Meditope's technology is capable of turning any monoclonal antibody (mAb) into a proprietary, site-specific "Lego-like" system that is able to attach and detach drugs to antibodies without the need for chemical conjugation. The result is a memAb (meditope-enabled mAb) product that is significantly more effective and offers multiple manufacturing advantages compared to existing antibody-drug conjugate technologies.

Neumedicines Inc. is a privately held biotechnology company developing protein therapeutics that address unmet clinical and societal needs in the areas of Oncology, Hematology and Immunology. NMIL12-1 (recombinant human interleukin-12 or rHuIL-12), the company’s lead product in development, targets multiple pathways of hematopoiesis and innate immunity and is being developed to address a broad range of clinical indications. 

Lion Biotechnologies is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (TILs).  This approach, also known as adoptive T-cell therapy, was developed by Dr. Steven A. Rosenberg at the National Cancer Institute and is currently in use at leading cancer centers in the US.

The SoCalBio Business Mixer bring together leaders from all segments of the life-science industry to share insights and learn about:

  • Innovation best practices
  • Device and biotech business trends
  • Technology convergence opportunities, and 
  • Broad-reaching public policies shaping the commercialization of innovations and healthcare service delivery in the U.S. and abroad.
Have questions about SoCalBio Networking Forum: Emerging Oncology Drugs? Contact Southern California Biomedical Council
Attendee List Sort by: Date | First Name | Last Name
Show More

When & Where

CNSI Auditorium at UCLA
570 Westwood Plaza
Los Angeles, CA 90024

Thursday, August 28, 2014 from 4:00 PM to 7:00 PM (PDT)

  Add to my calendar


Southern California Biomedical Council

The Southern California Biomedical Council is a nonprofit, member-supported trade association that supports and promotes life-science research, development, manufacturing, job creation and overall economic growth in the six counties that comprise the Greater Los Angeles region (Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino). The Council’s programs help local firms gain access to capital, potential partners and business support services. SoCalBio also promotes technology transfer and workforce training, while informing policy makers and the public at-large about the benefits of the region’s life-science industry.  SoCalBio is open to membership by firms and organizations engaged in life-science technology development and commercialization. More information is available at
  Contact the Organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.